Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorKöse, Nuri
dc.contributor.authorYıldırım, Tarık
dc.contributor.authorAkın, Fatih
dc.contributor.authorYıldırım, Seda Elçim
dc.contributor.authorAltun, İbrahim
dc.date.accessioned2022-09-13T11:29:58Z
dc.date.available2022-09-13T11:29:58Z
dc.date.issued2021en_US
dc.identifier.issn1512-8601 - 1840-4812
dc.identifier.urihttps://doi.org/10.17305/bjbms.2020.5292
dc.identifier.urihttps://hdl.handle.net/20.500.12462/12481
dc.descriptionYıldırım, Tarık (Balikesir Author)en_US
dc.description.abstractWe appreciate the comments made by Dr. Bedel et al. NLR, PLR, and LMR are affected by various diseases such as oncological, collagen tissue, inflammatory, or severe renal/liver diseases [1]. Due to this, we have listed some of the dis-orders mentioned above in the tables. Hematological diseases, collagen tissue disease, inflammatory diseases, congenital heart disease, or severe renal/liver disease were excluded from the study. However, the presence of malignancy did not affect our results in the regression analysis.en_US
dc.language.isoengen_US
dc.publisherAssoc Basic Medical Sci Federation Bosnia & Herzegovina Sarajevoen_US
dc.relation.isversionof10.17305/bjbms.2020.5292en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectResearch & Experimental Medicineen_US
dc.titleCan NLR, PLR, and LMR be used as prognostic indicators in patients with pulmonary embolism? Author's reply on commentary COMMENTen_US
dc.typeeditorialen_US
dc.relation.journalBosnian Journal of Basic Medical Sciencesen_US
dc.contributor.departmentTıp Fakültesien_US
dc.contributor.authorID0000-0002-6314-7371en_US
dc.identifier.volume21en_US
dc.identifier.issue4en_US
dc.identifier.startpage502en_US
dc.identifier.endpage502en_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess